The content on this site is intended for healthcare professionals only
For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Cancer patient symptom and physical function reporting by caregivers used as pre...
Dr Elad Neeman - Kaiser Permanente San Francisco Medical Center, San Francisco, ...
21 Jun 2022
War in Ukraine: Global cancer aid to support refugees
Dr Horia Vulpe , Dr Ruslan Baltaga
21 Jun 2022
ASCO and WHO to collaborate on quality indicators for cancer facilities
Dr André Ilbawi - WHO Headquarters, Geneva, Switzerland
14 Jun 2022
Spotlight on global cancer control at ASCO 2022
Prof Eduardo Cazap - Editor-in-Chief, ecancer and SLACOM
10 Jun 2022
UICC announces global coalition to increase access to essential cancer medicines...
Dr Cary Adams - Chief Executive Officer, Union for International Cancer Control
9 Jun 2022
Pancreatic neuroendocrine tumours: Capecitabine plus temozolomide gives longer P...
Dr Pamela Kunz - Yale Cancer Center, New Haven, USA
6 Jun 2022
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A re...
Dr Prateek Jain - Tata Medical Center, Kolkata, India
25 May 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
14 Apr 2022
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/...
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
13 Apr 2022
Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract...
Dr Do-Youn Oh - Seoul National University College of Medicine, Seoul, South Kore...
27 Jan 2022
HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients...
Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
27 Jan 2022
OncoAlert Colloquium Day 4: GI oncology and EONS
Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewi...
19 Jan 2022